cost-savings per 1000 patients**†1
In the first large-scale study directly comparing differing pressure levels in sNPWT devices found superior outcomes with PICO sNPWT at 30–90 days.1
(p<0.05**1)
Reduction in the odds of developing seroma**1
The PICO System helps reduce the odds of developing seroma, protecting mom and allowing more time to bond.1
(p=0.050**1)
Reduction in the odds of developing dehicence**1
Patients who received the PICO System after a C-section were significantly less likely to develop dehiscence, compared to other sNPWT.**1
(p=0.0050**1)
Kristie’s Story
How It Works
C-Section Application
- Vilkins A, Nherera L, Searle R, Welsh T. Prophylactic negative pressure wound therapy for caesarean section: a real world evidence study. Wounds. 2025;37(4):152–157.
- Saunders C, Nherera LM, Horner A, Trueman P. Single-Use negative-pressure wound therapy versus conventional dressings for closed surgical incisions: systematic literature review and meta-analysis. BJS Open. 2021;0(0):1 - 8.
- Bullough L, Burns S, Timmons J, Truman P, Megginson S. Reducing c-section wound complications. The Clinical Services Journal. 2015:2-6.
- Hyldig N, Möller S, Joergensen JS, Bille C. Clinical evaluation of scar quality following the use of prophylactic negative pressure wound therapy in obese women undergoing cesarean delivery: a trial-based scar evaluation. Ann Plast Surg. 2020 Jul 10. [Epub ahead of print]. Available at: Annals of Plastic Surgery
- Bullough L and Wilkinson D. Changing wound care protocols to reduce post-operative caesarean section complications. Presented at Wounds UK, Harrogate, 2012.
- Royal College of Obstetricians and Gynaecologists 2013. RCOG statement on emergency caesarean section rates [ONLINE].
- Michelle J.K. et all. Births: Final Data for 2020. National Vital Statistics Report. Vol. 70, 17. Available at: https://www.cdc.gov/nchs/data/nvsr/nvsr70/nvsr70-17.pdf.
*Compared with standard dressings in a woman with pre-pregnancy BMI ≥ 30
**Significant odds reductions in clinical outcomes were observed for patients receiving PICO sNPWT versus those receiving PREVENATM following C-section.
***Pre-pregnancy BMI ≥ 30
†Estimated using unadjusted data.